The Efficacy and Safety of Β-Nicotinamide Mononucleotide (NMN) as Anti-Aging Supplementation in Healthy Middle-Aged and Older (40-65 Years Old) Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Human Clinical Trial
Social Science Research Network(2022)
Key words
nmn,efficacy,anti-aging,middle-aged,double-blind,placebo-controlled,parallel-group,dose-dependent
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined